Evidence mapPaperPMID 42375498Full record

ArticleInternational journal of nephrology and renovascular disease2026

Cardiovascular Disease in Advanced Chronic Kidney Disease in a Tertiary Institution, Johannesburg, South Africa.

Zikho Mbenya, Unati Nqebelele, Umar G Adamu, Dineo Mpanya, Nqoba Tsabedze, Mduduzi Mashabane

Abstract read
In one paragraph

Article in International journal of nephrology and renovascular disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zikho MbenyaDepartment of Internal Medicine, Chris Hani Baragwanath Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Unati NqebeleleDivision of Nephrology, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Umar G AdamuDivision of Cardiology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.ORCID 0000-0002-5942-2668
Dineo MpanyaDivision of Cardiology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Nqoba Tsabedze *Division of Cardiology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Mduduzi Mashabane *Division of Nephrology, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among patients with advanced chronic kidney disease (CKD). However, data on its prevalence and patterns in Sub-Saharan Africa remain scarce. Purpose: To determine the prevalence and spectrum of CVD among patients with advanced CKD in Johannesburg, South Africa. Patients and Methods: This retrospective study enrolled adults aged ≥18 years with advanced CKD attending the renal clinic at Chris Hani Baragwanath Academic Hospital between 2009 and 2018. Demographic, clinical, laboratory, electrocardiographic, and echocardiographic variables were extracted from medical records. CVD was defined as heart failure, ischemic heart disease, arrhythmias, non-rheumatic valvular heart disease, pericardial disease, stroke, or peripheral vascular disease, supplemented by clinical, electrocardiographic, or echocardiographic findings. Patients were grouped by their CVD status. Multivariable logistic regression identified independent factors associated with CVD. Results: Among 300 participants (mean age of 55.3 ± 15.0 years, 54.3% males), CVD prevalence was 58.7%. The mean age at CVD diagnosis was 46.6 ± 13.7 years, with a median interval of 8.3 months (IQR, 2.5-27.6) between the onset of CKD and CVD diagnosis. Patients with CVD were younger than those without (52.8 ± 13.8 vs 58.8 ± 16.0 years; Conclusion: CVD is highly prevalent in advanced CKD and occurs at a young age. Early cardiovascular risk assessment and integrated cardio-renal management strategies are essential in this high-risk population.

Indexed as

cardiovascular diseasechronic kidney diseaseechocardiogramestimated glomerular filtration rateheart failureprevalence

Identifiers

PMID42375498
PMCPMC13313005

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.